Cardiology Fellow @EmoryHealthcare | Former IM Resident @BIDMCHealth | @StanfordMed Alum
Health outcomes research + delivery innovation | Medical education
The #racial breakdown of #COVID19 deaths is VERY alarming
Proportion of #COVID19 deaths in Black patients:
*Chicago - 68%
*Milwaukee - 81%
*Michigan - 41%
*Louisiana - 70%
The "...racial pandemic within the viral pandemic"
https://t.co/LvvXWPaIxd
Dear @GovKemp,
Please listen the the experts. Please protect my patients.
Please protect my family.
Please protect me.
Shut Georgia down.
Thank you,
A concerned physician mother, wife, daughter, sister, and constituent in Georgia
#shutdownnow#shutdownGA
New study in @JAMACardio!
How do hospitals that receive awards from the @American_Heart & @ACCinTouch for high quality cardiovascular care perform under @CMSGov pay-for-performance programs, which also target CV conditions?
The short answer? Not so well
https://t.co/zGtodS9plN
Tafamidis – recently approved for ATTR cardiomyopathy – is the most expensive cardiovascular drug ever launched in the US.
At $225000 a year, is it worth the $$?
Our work just released today @Circ_AHA
@HFpEF@rwyeh@djc795@jspertus@HFSA
https://t.co/uuoqTVM2Do
THREAD 1/
Congratulations to @rwyeh on being appointed the Katz Silver Family Professorship of Outcomes Research at Harvard Medical School!!
Bobby is a truly incredible and inspiring mentor, colleague, and friend. We are very lucky @SmithBIDMC@harvardmed
New work in @JAMAInternalMed & presented at @AHAMeetings
We find that individuals experiencing #homelessness are far less likely to receive procedural care for urgent cardiovascular conditions and have ↑ mortality rates than non-homeless adults.
https://t.co/uxpjPhs0Vk
New work in @bmj_latest
Under the HRRP, ↓ readmissions have been attributed to better transitional & post-d/c care.
We find, however, that total 30-day hospital revisits (ER, Obs, inpatient) have been **increasing** since the program was implemented
https://t.co/HDtKi8Ewpc
A new study led by BIDMC researchers @ColinWOBrien, @spjuraschek and @wee_christina finds widespread #aspirin use among Americans 40 years old and above, despite few benefits and high risks: https://t.co/9pH2CcpoVS
Millions of US adults who've never had cardiovascular disease could still be taking a daily aspirin to prevent heart disease, despite updated recommendations that say it may be unnecessary and possibly risky, new research suggests https://t.co/CX5kR3529p
Researchers found that up to 40 million healthy Americans still take aspirin to prevent a heart attack or stroke, which is no longer recommended for most people
Recent studies found that any benefits usually don’t outweigh the increased risk of stomach bleeding and other effects
During my last few rounds of chemo, I worked on this paper whenever I felt well enough to, taking breaks to nap on my office floor (or, once, my bathroom floor...). Today I showed it -- my first first-author paper -- to my oncologist. He asked for a copy to hang in his office. ☺️
"Aspirin use in the United States is widespread
among groups at risk for harm." As in many of the ~30 million adults taking it for primary prevention of heart disease.
https://t.co/3q7hfUdSqR survey results by @ColinWOBrien@spjuraschek@wee_christina@BIDMChealth@AnnalsofIM